The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Initial Management of Glycemia in Type 2 Diabetes Mellitus
Abstract
An asymptomatic 45-year-old Hispanic man has a fasting plasma glucose level of 142 mg per deciliter (7.9 mmol per liter) on initial evaluation and 139 mg per deciliter (7.7 mmol per liter) on reevaluation. Other than a steady gain in weight since college and borderline hypertension, his medical history is unremarkable. He is 175 cm (5 ft 9 in.) tall and weighs 95 kg (209 lb; body-mass index, 31.2), and his blood pressure is 138/88 mm Hg. Physical examination is notable only for abdominal obesity and absent ankle reflexes. How should this patient be treated?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“inflammation and thrombosis[75]”
From Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial (2016) · cites this paper as [75]
Citations
Cites
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803
Research works printed but not linked: 5
- 1990, Diabetes Res, 13, 1
- 10.1001/jama.241.19.2035 · DOI · Paper page
- 1993, N Engl J Med, 329, 978
- 10.1001/archinte.157.21.2413 · DOI · Paper page
- Genuth SM, 1987, Clin Diabetes, 5, 74
Cited by
Sorted by citations
Items 201–300 of 366
Green, D. E. (2007) · Clinical cornerstone · doi:10.1016/s1098-3597(09)60008-9 · Cited by 9
Weight Gain and Management Concerns in Patients on Insulin Therapy
Westphal, S. A., & Palumbo, P. J. (2007) · Insulin · doi:10.1016/s1557-0843(07)80031-5 · Cited by 8
What Options Are Available When Considering Starting Insulin: Premix or Basal?
Lavernia, F. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0248 · Cited by 9
Defining and characterising the progression of type 2 diabetes
Fonseca, V. A. (2008) · The British Journal of Diabetes · doi:10.1177/1474651408100520 · Cited by 9
The treat-to-target A1C approach to control type 2 diabetes and prevent complications
White, R. D. (2007) · Advances in Therapy · doi:10.1007/bf02848777 · Cited by 9
Vizioli, C., Jaime-Lara, R. B., Franks, A. T., Ortiz, R. V., & Joseph, P. V. (2020) · Biological Research For Nursing · doi:10.1177/1099800420942900 · Cited by 9
Nuho, A., Subekti, I., Ismail, D., & Sitompul, R. (2004) · PubMed · Cited by 8
Diabetes diagnosis and exercise initiation among older Americans
Leung, L. A., Swaminathan, S., & Trivedi, A. N. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.05.001 · Cited by 7
Rosas-Guzmán, J., & Lyra, R. (2010) · Revista de Endocrinología y Nutrición · Cited by 7
Xin, Y., Zhou, S., Wang, H., Hu, B., Zhang, Z., Wang, J., & Sun, T. (2021) · New Journal of Chemistry · doi:10.1039/d1nj02510d · Cited by 7
A New Look at Established Therapies
Gavin, J. R., Peragallo‐Dittko, V., & Rodgers, P. T. (2010) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721710369637 · Cited by 7
Laires, P. A., Kurtyka, K., Witt, E. A., Qiu, Y., Yu, S., & Iglay, K. (2018) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2018.1510774 · Cited by 7
Min, K. L., Koo, H., Choi, J. J., Kim, D. J., Chang, M. J., & Han, E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210159 · Cited by 7
Progression of Type 2 Diabetes and Insulin Initiation
Rolla, A. R. (2011) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30296-0 · Cited by 7
Willett, L. L., & Albright, E. S. (2004) · Southern Medical Journal · doi:10.1097/01.smj.0000140831.28281.7e · Cited by 7
Status of thyroid profile in Type-2 diabetes mellitis
Yadav, S. C., Saldhana, A., & Majumdar, B. (2012) · Journal of Nobel Medical College · doi:10.3126/jonmc.v1i2.7302 · Cited by 7
Varma, S., & Piatt, G. (2013) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2013.34031 · Cited by 7
Expanding Treatment Options for Type 2 Diabetes The Old and the New
Pratley, R. E. (2009) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721709331522 · Cited by 7
Kelaher, M., Taylor‐Thomson, D., Harrison, N., O’Donoghue, L., Dunt, D. R., Barnes, T. S., & Anderson, I. (2004) · Cited by 7
Is There a Rationale for Insulin Therapy in Pre-Diabetic Individuals?
Schwartz, S. L. (2006) · Treatments in Endocrinology · doi:10.2165/00024677-200605060-00007 · Cited by 7
Constantinou, G., Melides, S., & Modell, B. (2003) · New England Journal of Medicine · doi:10.1056/nejm200302273480919 · Cited by 7
Bhandarkar, N. S., Shetty, K. B., Shetty, N., Shetty, K., Kiran, A., Pindipappanahalli, N., Shetty, R., & Ghosh, A. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1394298 · Cited by 7
Nuclear Peroxisome Proliferator-Activated Receptors and Thiazolidinediones
Oren-Grinberg, A., & Park, K. W. (2005) · International Anesthesiology Clinics · doi:10.1097/01.aia.0000157485.91241.0b · Cited by 6
Ajayi, E., Ajayi, A., & Olalekan, O. (2010) · Internet Journal of Medical Update - EJOURNAL · doi:10.4314/ijmu.v5i2.56155 · Cited by 6
THE SWEET FOOT Relation of Glycemic Control with Diabetic Foot Lesions
Akbar, N., & Bilal, N. (2018) · International Journal of Pathology · Cited by 6
Čabarkapa, V., Đerić, M., Stosić, Z., Sakač, V., Davidović, S., & Eremić, N. (2013) · Journal of Medical Biochemistry · doi:10.2478/jomb-2013-0003 · Cited by 6
Diabetes Mellitus and Cardiovascular Disease in the Elderly
Gregoratos, G., & Leung, G. (2008) · Fundamental and clinical cardiology · doi:10.3109/9781420061710.007 · Cited by 6
Ramsingh, J., & Bhuvaneswari, V. (2018) · International Conference on Intelligent Computing and Control Systems (ICICCS) · doi:10.1109/iccons.2018.8663143 · Cited by 6
Saul, S. R., & KASE, N. G. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13952 · Cited by 6
Treating type 2 diabetes: targeting the many causative factors.
Sutherland, J. E., & Hoehns, J. D. (2004) · PubMed · Cited by 6
Lispro Is Superior to Regular Insulin in Transient Intensive Insulin Therapy in Type 2 Diabetes
Murase, Y., Yagi, K., Sugihara, M., Chujo, D., OTSUJI, M., Muramoto, H., & Mabuchi, H. (2004) · Internal Medicine · doi:10.2169/internalmedicine.43.779 · Cited by 6
A case for introducing insulin early in the treatment of type 2 diabetes mellitus
Westphal, S. A., & Palumbo, P. J. (2006) · Insulin · doi:10.1016/s1557-0843(06)80012-6 · Cited by 6
Protease Inhibitor–Associated Diabetes Mellitus: A Potential Cause of Morbidity and Mortality
Fantry, L. E. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200303010-00001 · Cited by 6
Initial Management of Glycemia in Type 2 Diabetes
Banarer, S. (2003) · New England Journal of Medicine · doi:10.1056/nejm200302203480819 · Cited by 6
Chan, J. C. N., Deerochanawong, C., Khunti, K., Hassanein, M. M., & Mohan, V. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113173 · Cited by 6
Wang, Y.-F., Kong, X.-H., Tao, H., & Li, T. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s464490 · Cited by 5
Diagnóstico y tratamiento de la diabetes mellitus tipo 2
Gil-Velázquez, L. E., Sil-Acosta, M. J., Dominguez-Sanchez, E., Torres‐Arreola, L. D. P., & Medina-Chávez, J. H. (2013) · Revista M�dica del Instituto Mexicano del Seguro Social · Cited by 5
Oral Agents in Managing Diabetes Mellitus in Children and Adolescents
Jacobson-Dickman, E. E., & Levitsky, L. L. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2005.07.008 · Cited by 5
Breukelman, G. J., Basson, A. K., Djarova, T. G., Shaw, B. S., Preez, C. J. D., & Shaw, I. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06266 · Cited by 5
Abubakari, B. B., Ibrahim, M. M., Mutawakilu, I., Maury, C. P., Álvarez, V. R., Triana, M. H., & Pianesi, M. (2014) · Internal Medicine Inside · doi:10.7243/2052-6954-2-3 · Cited by 5
Inhaled Human [rDNA Origin] Insulin, a Novel Formulation for Diabetes Mellitus
Pham, D. Q., Cohen, H., & Chu, V. L. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007301798 · Cited by 5
Sun, Y., Shao, L., Niu, X., Liu, Y., Ge, J., Jiang, H., & Zhang, H. (2014) · Journal of International Medical Research · doi:10.1177/0300060514529555 · Cited by 5
What is the role for insulin therapy in type 2 diabetes?
Leahy, J. L. (2003) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200304000-00001 · Cited by 5
Nussinovitch, U., & NUSSINOVITCH, A. (2011) · doi:10.1002/9781118015810.ch5 · Cited by 5
Introductory Remarks: Diabetes Care in America - “A Sense of Urgency”
Davidson, J. A. (2006) · Endocrine Practice · doi:10.4158/ep.12.s1.13 · Cited by 5
Counterpoint: No Time to Inhale: Arguments Against Inhaled Insulin in 2007
Nathan, D. M. (2007) · Diabetes Care · doi:10.2337/dc06-2331 · Cited by 5
Narumi, T., Watanabe, T., Kato, S., Tamura, H., Nishiyama, S., Takahashi, H., Arimoto, T., Shishido, T., & Watanabe, M. (2019) · Circulation Reports · doi:10.1253/circrep.cr-19-0033 · Cited by 4
Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
Schwartz, S. S. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s6742 · Cited by 4
Peripheral Pathways in the Food-Intake Control towards the Adipose-Intestinal Missing Link
Zerón, H. M., García, M. V. D., Romero, M. D. S. C., & Flores‐Merino, M. V. (2013) · International Journal of Endocrinology · doi:10.1155/2013/598203 · Cited by 4
Nourizadeh, A., Herbin, M., Lukas-Croisier, C., Novella, J., & Delemer, B. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0044 · Cited by 4
Validity study of the Turkish version of the barriers to insulin treatment questionnaire
Sarıtaş, S. Ç., Erci, B., Şahin, İ., & Timocin, E. (2018) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0670-x · Cited by 4
Case Studies and Enrichment References
Bhagavan, N. V., & Ha, C. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-095461-2.00038-2 · Cited by 4
Babar, T., & Skugor, M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6643-9.00232-0 · Cited by 4
Zhang, X., Brooks, B. A., Molyneaux, L. M., LANDY, E., Banatwalla, R., Wu, T., Wong, J., Su, B., & Yue, D. K. (2014) · International Journal of Endocrinology · doi:10.1155/2014/354040 · Cited by 4
Experimental and clinical pharmacology: Clinical indications for thiazolidinediones
MacIsaac, R. J. (2004) · Australian Prescriber · doi:10.18773/austprescr.2004.060 · Cited by 4
Mechanism-Based Modeling of the Glucose-Insulin Regulation during Clinical Provocation Experiments
Jauslin-Stetina, P. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 4
Caporale, J., Pichón-Rivière, A., Beratarrechea, A. G., Schulz-Hausmann, C. V., & Augustovski, F. (2014) · Value in Health Regional Issues · doi:10.1016/j.vhri.2014.02.007 · Cited by 3
Sto, Z., Saka, V., Davidovi, S., & Eremi, N. (2013) · Cited by 3
Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
Schwartz, S. S. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s6742 · Cited by 3
Andreoli, B., Mantovani, A., & Andreoli, C. (2020) · Journal of Clinical and Translational Endocrinology Case Reports · doi:10.1016/j.jecr.2020.100061 · Cited by 4
Hong, I. K., Kim, J., Lee, Y. J., Choe, Y.-M., Choi, S. K., Lee, K. Y., Kim, S.-J., Cho, Y. U., Ahn, S., Hong, K. C., et al. (2011) · Journal of the Korean Surgical Society · doi:10.4174/jkss.2011.80.2.103 · Cited by 3
Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review
Raskin, P., & Fordan (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3402 · Cited by 3
Treatment for Childhood Type 2 Diabetes
Urakami, T. (2005) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.14.1 · Cited by 3
Unmasking in an observational vaccine safety study: Using type 2 diabetes mellitus as an example
Ackerson, B. K., Sy, L. S., Slezak, J. M., Chao, C., Hechter, R. C., Takhar, H. S., & Jacobsen, S. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.080 · Cited by 3
Type 2 Diabetes Mellitus and Its Effect on Vascular Disease
Chorzempa, A. (2006) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200611000-00014 · Cited by 3
Monjo, M. C., Sánchez, O. D., Bosch, P. V., Fló, A. L., Blanco, M., Torralva, A. E., Latorre, F. P., & Martínez‐López, I. (2004) · PubMed · Cited by 3
Massachusetts Guidelines for Adult Diabetes Care
(2009) · State Library's electronic repository (State Library of Massachusetts) · Cited by 3
Determining the Factors that Influence the Insulin Requirements in Type 2 Diabetic Patients
Chung, J. O., Cho, D. H., Chung, D. J., & Chung, M. Y. (2010) · Endocrinology and Metabolism · doi:10.3803/enm.2010.25.2.110 · Cited by 2
Gulsen, G., & Olgun, N. (2016) · International Diabetes Nursing · doi:10.1080/20573316.2016.1242878 · Cited by 2
Is daytime insulin more physiologic and less atherogenic than bedtime insulin?
Kanat, M. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.10.037 · Cited by 2
Will the epidemic of diabetes in India subside?
Chandalia, H. B. (2011) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-011-0027-1 · Cited by 2
Martínez-Laguna, D., Nogués, X., Díez‐Pérez, A., Soria-Castro, A., Carbonell-Abella, C., Arias-Moliz, I., Estrada‐Laza, P., & Prieto‐Alhambra, D. (2013) · Revista de Osteoporosis y Metabolismo Mineral · doi:10.4321/s1889-836x2013000200003 · Cited by 2
Management of Type 2 Diabetes Mellitus with Basal-Prandial Insulin Therapy: A Case-Based Review
Davis, S. N. (2007) · Insulin · doi:10.1016/s1557-0843(07)80040-6 · Cited by 2
Insulin Initiation During a 20-Minute Office Visit: Part 1: Setting the Scene
Valentine, V. (2010) · Diabetes Spectrum · doi:10.2337/diaspect.23.3.188 · Cited by 2
Gupta, A. K., Sabarwal, N., Patidar, A., Patel, A., & Agrawal, Y. P. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9740-z · Cited by 2
Drug-Induced Hyperglycemia and Diabetes Mellitus
McCullen, M. K., & Ahmed, I. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-35 · Cited by 2
Is Weight Gain an Unavoidable Consequence of Insulin Therapy?
(2007) · The Internet Journal of Internal Medicine · doi:10.5580/1cb5 · Cited by 2
Grape Seed Extract and its Effects on Diabetes and its Complications
Vasanthi, H. R. (2017) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2017.02.555584 · Cited by 2
The STOP DIABETES study: when prevention works
Bonaventura, A., & Montecucco, F. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01309-6 · Cited by 2
An Uncompromising Approach to Achieving Glycemic Goals
Gavin, J. R. (2007) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721707301209 · Cited by 2
Marks, J. (2007) · CRC Press eBooks · doi:10.3109/9780203931592-2 · Cited by 2
Lagunes-Córdoba, R., Guevara, I. G., Reyes, A. C., Aparicio, C. R., & Rosas-Santiago, F. J. (2017) · Salud Colectiva · doi:10.18294/sc.2017.1341 · Cited by 5
Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus
Mathieu, C. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.5.779 · Cited by 2
Role of AMPK in aging and age-related loss of behavioral plasticity in C. elegans
Escoubas, C. C. (2018) · theses.fr (ABES) · doi:10.70675/1c8dd62ez2561z4581zaa55z169311331b91 · Cited by 2
The phenotype masks the genotype: A possible new expression of diabetes.
Mimbacas, A., Vitarella, G., Souto, J., Reyes, A. L. J., Farías, J., Fernández, M., Fabregat, M., & Javiel, G. (2012) · Europe PMC (PubMed Central) · doi:10.3233/pge-2012-021 · Cited by 1
Dujunco, M. M., Gorriceta, J. H., Dampil, O. A., & Mirasol, R. C. (2014) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.029.02.11 · Cited by 1
The Many Faces of Type 2 Diabetes
Flood, T. M. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.07.2190 · Cited by 1
Karet, B. (2008) · Primary Care Cardiovascular Journal (PCCJ) · doi:10.3132/pccj.2008.004 · Cited by 1
The impact of evidence-based medicine on diabetes therapy
Görden, P., & Musso, C. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0001-8 · Cited by 1
The Wrong Tool for the Job: Diabetes Public Health Programs and Practice Guidelines
Sarkar, U., López, A., Black, K. P., & Schillinger, D. (2011) · American Journal of Public Health · doi:10.2105/ajph.2011.300148 · Cited by 1
Alhadidi, Q., Sahib, A. S., Jaffer, A. M., Ismael, M. H., Hassan, E. K., Shareef, S. M., Shoesh, A. M., & Dawood, A. S. (2012) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2012.2719 · Cited by 1
Insulinophobia: Existence of an Infamous Reality In Primary Health Care
Chary, K. V., & Swaminathan, P. (2016) · Journal of Young Pharmacists · doi:10.5530/jyp.2016.2.16 · Cited by 1
Diabetes in the Elderly: Exercising Your Clinical Skills
Zettervall, D. K., Shane‐McWhorter, L., & Triplitt, C. L. (2010) · The Consultant Pharmacist · doi:10.4140/tcp.sb.2010.1 · Cited by 1
The Wisconsin Medical Society diabetes study.
Helstad, C. P., Wiegmann, S. M., Camponeschi, J. L., Udlis, S., & Meredith, M. (2004) · PubMed · Cited by 1
Malik, M., Hassali, M. A., Shafie, A. A., & Hussain, A. (2014) · Eastern Mediterranean Health Journal · doi:10.26719/2014.20.4.221 · Cited by 1
A Review on Drug Related Problems in Type 2 DM with Combination of Sulfonylureas and Biguanides
Jose, C., Pradhan, A., & Shabaraya, A. R. (2021) · International Journal of Research and Review · doi:10.52403/ijrr.20210633 · Cited by 1
Florez, H. J., Sánchez, A. A., & Marks, J. B. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-850-8_2 · Cited by 1
Fuzzy Inference Model for Type 2 Diabetes Management: a Tool for Regimen Alterations
Nnamoko, N., Arshad, F., England, D., Vora, J. P., & Norman, J. E. (2015) · Edge Hill University Research Information Repository (Edge Hill University) · doi:10.12691/jcsa-3-3a-5 · Cited by 1
Fixed-dose combination of pioglitazone and glimepiride in the treatment of Type 2 diabetes mellitus
Forst, T. M., & Pfützner, A. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.3.303 · Cited by 1
Metadata
- Authors
- Nathan, D. M.
- Affiliations
- Harvard University (US)
- Corresponding author
- Nathan, David M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-10-24
- Volume
- 347
- Issue
- 17
- Pages
- 1342-1349
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2090609048
- Cited by
- 359
- References
- 57
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 6 · 2019: 8 · 2018: 9 · 2017: 13 · 2016: 13 · 2015: 7 · 2014: 20 · 2013: 16 · 2012: 15
- FWCI
- 14.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, glycemic control, initial management, fasting blood glucose, obesity, borderline hypertension, Hispanic patients, weight gain
- MeSH terms
- Combined Modality Therapy, Diabetes Mellitus, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Humans, Hyperglycemia, Hypoglycemic Agents, Male, Middle Aged, Obesity, Weight Loss, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
